Literature DB >> 4110537

General considerations in intermittent drug therapy of pulmonary tuberculosis.

W Fox.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4110537      PMCID： PMC2467339          DOI： 10.1136/pgmj.47.553.729

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  16 in total

1.  FURTHER EXPERIMENTS ON LONG-TERM CHEMOTHERAPY OF ADVANCED MURINE TUBERCULOSIS, WITH EMPHASIS ON INTERMITTENT REGIMES.

Authors:  F GRUMBACH; G CANETTI; J GROSSET
Journal:  Tubercle       Date:  1964-06

2.  Studies on prevention of experimental tuberculosis with isoniazid. II. Effects of different dosage regimens.

Authors:  S H FEREBEE; L HOPWOOD; C E PALMER
Journal:  Am Rev Tuberc       Date:  1956-12

3.  The control of experimental mouse tuberculosis by the intermittent administration of streptomycin, viomycin, isoniazid, and streptomycylidene isonicotinyl hydrazine.

Authors:  G L HOBBY; T F LENERT
Journal:  Am Rev Tuberc       Date:  1953-08

4.  [Intermittent treatment of experimental tuberculosis in mice with isonicotinic acid hydrazide].

Authors:  F GRUMBACH; N RIST; J RIEBEL
Journal:  Ann Inst Pasteur (Paris)       Date:  1952-09

5.  The Remote Sustained Threshold Therapeutic Action of Streptomycin in Tuberculosis.

Authors:  H J Corper; M L Cohn
Journal:  Science       Date:  1947-11-07       Impact factor: 47.728

6.  A double-blind study to determine the maximum tolerated dose of ethionamide, when administered twice-weekly to patients with pulmonary tuberculosis.

Authors:  S Devadatta; N K Menon; O Nazareth; S Radhakrishna; C V Ramakrishnan; P R Somasundaram; S P Usha; S Velu
Journal:  Tubercle       Date:  1970-09

7.  Suitability of isoniazid and ethambutol for intermittent administration in the treatment of tuberculosis.

Authors:  J M Dickinson; G A Ellard; D A Mitchison
Journal:  Tubercle       Date:  1968-12

8.  A study of acute intolerance to ethionamide, including a comparison with prothionamide, and of the influence of a vitamin B-complex additive in prophylaxis.

Authors:  W Fox; D K Robinson; R Tall; P W Kent; D M Macfadyen
Journal:  Tubercle       Date:  1969-06

9.  Rifampicin in daily and intermittent treatment of experimental murine tuberculosis, with emphasis on late results.

Authors:  F Grumbach; G Canetti; M Le Lirzin
Journal:  Tubercle       Date:  1969-09

10.  Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis. 3. Serum concentrations of isoniazid produced by three regimens of isoniazid alone and one of isoniazid plus PAS.

Authors:  P R GANGADHARAM; S DEVADATTA; W FOX; C N NAIR; J B SELKON
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408
View more
  3 in total

1.  Comparative blood levels and metabolism of INH and an INH-matrix preparation in fast and slow inactivators.

Authors:  C W Jeanes; O Schaefer; L Eidus
Journal:  Can Med Assoc J       Date:  1973-09-15       Impact factor: 8.262

2.  Compliance of patients and physicians: experience and lessons from tuberculosis-II.

Authors:  W Fox
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-09

Review 3.  Pharmacokinetic factors in the modern drug treatment of tuberculosis.

Authors:  J G Douglas; M J McLeod
Journal:  Clin Pharmacokinet       Date:  1999-08       Impact factor: 6.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.